UCB is a global biopharmaceutical company with a focus on neurology and immunology. Our medicines treat thousands of people around the world. We engage with patients, families and healthcare professionals to address unmet needs.
We are around 7500 people in all four corners of the globe, inspired by patients and driven by science.